Ilyang gets nod for ilaprazole in Korea

Published: 2008-10-31 07:00:00

Updated: 2008-10-31 07:00:00

Ilyang Pharmaceutical Co., Ltd., announced on October 28 that they received marketing approval from the Korean Food and Drug Administration (KFDA) for ilaprazole a new investigational proton pump inhibitor, following the approval of the Chinese drug regulatory agency in May.

Ilaprazole will be marketed in Korea under the brand name Nortec in 10 mg tablet strength.

The KFDA said ilaprozole...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.